Updated : May 05, 2020 09:18 PM IST
As per tests conducted at Rome’s infectious-disease Spallanzani Hospital, the coronavirus vaccine has antibodies generated in mice that work on human cells.All of the vaccine candidates currently being developed are based on the genetic material of DNA protein ‘spike’.
Italy has claimed that it has successfully developed the world’s first coronavirus vaccine that works on humans, Arab News has reported. As per the tests carried out at Rome’s infectious-disease Spallanzani Hospital, the coronavirus vaccine has antibodies generated in mice that work on human cells.
“This is the most advanced stage of testing of a candidate vaccine created in Italy,” Luigi Aurisicchio, CEO of Takis, the firm developing the medication told Italian newsagency ANSA in a report.
CNBCTV18.com could not independently verify the reports.
“Human tests are expected after this summer,” Aurisicchio was quoted as saying.
Scientists used mice to test the vaccine and after a single vaccination, the mice developed antibodies that blocked the virus from infecting the human cells.
After observing that the five vaccine candidates generated a large number of antibodies, researchers selected two with the best results, the report said.
All of the vaccine candidates currently being developed are based on the genetic material of DNA protein “spike”.“So far, the immunity generated by most of our five vaccine candidates has an effect on the virus. We expect better results after the second vaccination,” Dr Emanuele Marra from Takis was quoted as saying. He added that the vaccine candidates could adapt to any COVID-19 evolution and its possible mutations.